NCT06974747View on ClinicalTrials.gov

Immunomodulatory Effect of Pleuran in Children With Recurrent Respiratory Tract Infections

NACompletedINTERVENTIONAL
Enrollment

217

Participants

Timeline

Start Date

September 25, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Respiratory Tract Infection
Interventions
DIETARY_SUPPLEMENT

Imunoglukan P4H® chewable tablets

IMG® 50 mg + Zinc 5 mg + Vitamin D 10 μg in 1 tablet

DIETARY_SUPPLEMENT

Placebo chewable tablets

Zinc 5 mg + Vitamin D 10 μg in 1 tablet

Trial Locations (3)

11000

IMUNOGLUKAN CZ, s.r.o., Prague

11070

Medis Pharma d.o.o. Beograd, Belgrade

82105

Imunoglukan, s.r.o., Bratislava

All Listed Sponsors
lead

Pleuran, s.r.o.

INDUSTRY

NCT06974747 - Immunomodulatory Effect of Pleuran in Children With Recurrent Respiratory Tract Infections | Biotech Hunter | Biotech Hunter